Connect Biopharma Holdings Limited
Healthcare / Biotechnology
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Performance
--
Today 0.00 (0.00%)
CNTB
Metrics
Market Cap74M
Latest Price$1.23
Previous Close$1.24
Volume12M
52 Week High$3.82
52 Week Low$1.06
52 Week Change7.14%
Average Volume704K
Revenue3M
EPS-1.19
P/E Ratio0
Forward P/E-1.676
Price/Book2.74
Profit Margin0.00%
Operating Margin-6.36%
Return on Equity-1.41%
Dividend Yield0.00%